Clinical value of enzyme immunoassay that detects rubella-specific immunoglobulin M immediately after disease onset

Takako Kurata1, Kiyoko Uchino2, Chiemi Hotta3

  • 1Osaka Institute of Public Health, 1-3-69, Nakamichi, Higashinari-ku, Osaka, 537-0025, Japan.

Microbiology and Immunology
|December 15, 2018
PubMed

Insights

The rubella-specific IgM test is clinically valuable for diagnosing rubella in adults. IgM antibody levels and positive rates significantly increase three days after rash onset, aiding in timely diagnosis.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Medicine

Background:

  • Rubella, a viral infection, poses risks, especially to adults.
  • Accurate and timely diagnosis is crucial for managing rubella outbreaks and patient care.

Purpose of the Study:

  • To evaluate the clinical utility of a rubella-specific IgM enzyme immunoassay (EIA) test.
  • To determine the optimal timing for IgM testing post-rubella symptom onset.

Main Methods:

  • Investigated 300 adult patients with confirmed rubella via nucleic acid testing.
  • Utilized a rubella-specific IgM enzyme immunoassay (EIA) kit.
  • Analyzed IgM titers and positive rates at various time points after rash onset.

Main Results:

  • Median IgM titers significantly increased by 3 days post-rash onset (P < 0.0001).
  • The IgM-positive rate reached 61.5% at 3 days post-onset, significantly higher than earlier time points (P < 0.0001).

Conclusions:

  • The rubella-specific IgM EIA test provides clinically relevant diagnostic information.
  • Testing for rubella IgM antibodies at 3 days or more after disease onset is recommended for accurate diagnosis.

Related Concept Videos

Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
94.7K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
650
Enzyme Kinetics01:19

Enzyme Kinetics

Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
104.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
942
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
217